Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111411094B discloses a novel mutant enzyme achieving 95.4% conversion at high substrate concentrations, offering significant cost reduction in API manufacturing.
Patent CN108866021B details a novel transaminase mutant for synthesizing sitagliptin intermediates with >99% ee. Discover cost-effective biocatalytic solutions for API manufacturing.
Novel preparation method for Arotinolol Hydrochloride via CN112300149A. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing through one-pot coupling.
Novel omega-aminotransferase mutant enables high-yield sitagliptin intermediate production with 99% ee value and reduced solvent constraints for global supply chains.
Patent CN1111531C details a scalable xylene-based process for castanospermine esters, offering significant cost reduction in pharma manufacturing and enhanced supply reliability.
Patent CN110540975B reveals high-efficiency biocatalytic route for sitagliptin precursors, offering superior stereoselectivity and reduced environmental impact for pharma supply chains.
Patent CN100379733C reveals a high-yield synthesis for triazole antifungal intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN104926802B details improved synthesis for neuraminic acid derivatives offering enhanced purity and operational efficiency for global pharmaceutical intermediate supply chains.
Patent CN111875591B details a green one-pot synthesis for benzopyrone intermediates using recyclable ionic liquids, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN101747304B reveals a green Zn/PEG/H2O method for vinyl sugar synthesis, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118374465B reveals enzymatic route for (S)-nicotine. Achieves 99.1% ee value. Offers scalable biocatalysis for reliable pharmaceutical intermediates supplier chains.
Novel alkylation and conductivity-based layering process reduces wastewater and boosts yield for high-purity aniline dye intermediates, offering significant cost and supply chain advantages.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN110240560B reveals a green oxidation route for herbicide intermediates, offering cost reduction and high purity for reliable agrochemical intermediate supply chains.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Patent CN111689881A reveals a catalytic sulfonation method for 4-chloro-2-fluoro-5-sulfamoylbenzoic acid, offering high purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN102093432A details a high-yield rhodium catalyst synthesis. This report analyzes cost reduction and supply chain reliability for chemical manufacturing.
Patent CN111172213B reveals dual-enzyme tandem method for L-ABA. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN113651864A reveals a safer synthesis route for Diquafosol Tetrasodium using inorganic ammonia, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.